Provider review
REMEVi review
Names four pharmacies right on your vial label — a correction to "not named"
A genuinely bilingual clinic, with clinicians who speak Spanish rather than a translated site. Semaglutide runs $219 a month down to $149 on a year plan, tirzepatide $319 to $199, and the pharmacy that filled your vial is printed on the label.
Straight talk: how we earn — some, not all, of these are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
On this page
The verdict
REMEVi discloses more than most providers in this category and does it plainly: four named pharmacies right on the homepage, a self-disclosed admission that its press mentions are paid syndication rather than earned coverage, and flat pricing that doesn't climb as your dose does. The main thing to plan around is the pricing structure itself — the lowest published rate requires a full 52-week commitment, and month-to-month runs meaningfully higher ($219 vs $149 for semaglutide). None of that is hidden, but it's worth budgeting for before you assume the lowest advertised number is what you'll pay.
REMEVi is not ranked on any of our rankings. This is a standalone read of what the company publishes about itself — the providers we do rank in this category are on our semaglutide provider ranking. Nothing on this page is a performance claim — see the evidence review for what these compounds do and do not do.
Who it is for, and who it is not
A good fit if
- You want genuinely bilingual care (English/Spanish), not just translated marketing copy
- You want named pharmacies you can independently verify rather than a vague "licensed network" claim
- You're comfortable committing to a 52-week plan to get the lowest published rate
Look elsewhere if
- You want month-to-month flexibility at the lowest advertised price — that requires the 52-week commitment
- You're impressed by its Fortune/AP/Reuters mentions — REMEVi's own site discloses these are paid syndication, not editorial coverage
- You want brand-name (not compounded) GLP-1 options
What it actually costs
What they advertise
Semaglutide: $149/mo on a 52-week plan on remevihealth.com.
What you actually pay, month to month
Month-to-month runs $219/mo for semaglutide and $319/mo for tirzepatide — meaningfully higher than the 52-week rate.
The commitment trap
The lowest advertised price requires a 52-week commitment; the true month-to-month rate is $219 for semaglutide, 47% higher than the $149 headline figure.
Checked live on REMEVi's own site at https://remevihealth.com/pricing/ in August 2026. Prices change without notice — confirm before you buy. Work out what a vial actually gives you with our peptide dose calculator.
What is included
The cheapest headline number in this category is often the one with the least attached to it. Here is what REMEVi bundles in, and what it does not.
Clinician consult
24-hour provider review.
Bloodwork / labs
Quarterly labs and EKG review.
Follow-ups and dose changes
Monthly titration.
Human support
Unlimited bilingual coordinator messaging.
Injection supplies
Injection supplies included.
Shipping
Cold-chain shipping.
Pharmacy, labs and oversight
The pharmacy
RedRock Pharmacy, Health Warehouse, Precision Medicine, or Triad Rx — four named pharmacies, assigned by your state.
Oversight
Monthly titration.
Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Our guide to verifying a certificate of analysis covers what to ask for.
Where you can get it
All 50 states plus DC.
The honest cons
The part they would rather you skipped
REMEVi's own /press/ page states plainly that its Fortune, AP, and Reuters mentions are "syndicated press-release placements, not editorial endorsements," — an unusually honest disclosure worth noting, since most sites let readers assume the opposite.
- Lowest pricing requires a full 52-week commitment; month-to-month runs 47% higher
- Compounded medications are not FDA-approved — no brand-name Wegovy or Zepbound option
- Press mentions are self-disclosed as paid syndication, not editorial coverage
- A newer, patient-founded clinic without a long independent track record
None of this is unique to REMEVi — the whole category shares it. What we hold against a provider is the part it hides, and the ways vendors hide things are cataloged in our vendor red-flags guide.
How it compares
The providers we rank on our semaglutide provider ranking, in the order that ranking ranks them. REMEVi is not among them: it is reviewed here, not ranked there, and we would rather show you the comparison than pretend the two are the same thing.
- COCollectiveThe cheapest medication price here, on a membership the headline omits
- CoreAge RxOne price that does not move when your dose does
- BHBodybuilding Health+The deep peptide catalog is gone; the GLP-1 pricing got better
- RxSpan MDOral tablet only, at a real $179 monthly rate
- Enhance MDWrites a flat-price-at-every-dose policy down — and charges near the top for it
- Found HealthInsurance-integrated, unlike every cash-only compounder here — but $99 needs a prepay
- Direct MedsThe plainest price mechanics on either ranking, from a company with an FDA warning letter
- Synergy RxPublishes a starting number, and nothing about what it commits you to
13 more providers rank on our semaglutide provider ranking — see the full ranking. Every provider we review →
Read this before you buy
A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Facts on this page reflect REMEVi's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on REMEVi's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.